Lord, Abbett & Co
NTUS

Lord, Abbett & Co’s Natus Medical Inc NTUS Stock Holding History

Lord, Abbett & Co’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-87,562
Closed -$1.75M – 712
2020
Q4 		$1.75M Sell
87,562
-334,491
-79% -$6.55M ﹤0.01% 632
2020
Q3 		$7.23M Buy
422,053
+41,400
+11% +$783K 0.02% 520
2020
Q2 		$8.31M Sell
380,653
-10,496
-3% -$240K 0.03% 507
2020
Q1 		$9.05M Sell
391,149
-57,900
-13% -$1.68M 0.04% 453
2019
Q4 		$14.8M Sell
449,049
-15,963
-3% -$512K 0.05% 446
2019
Q3 		$14.8M Buy
465,012
+439,159
+1,699% +$12.8M 0.05% 463
2019
Q2 		$664K Buy
+25,853
New +$659K ﹤0.01% 746

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Lord, Abbett & Co's NTUS Position: Q1 2021 in Review

Lord, Abbett & Co sold out of Natus Medical Inc (NTUS) in Q1 2021, closing a stake of 87,562 shares — an estimated $1.75M sold.

Lord, Abbett & Co first reported a position in NTUS in Q2 2019 and held it in 7 quarters. The position peaked at $14.8M in Q4 2019. 156 funds tracked by Wall St. Rank hold NTUS as of Q1 2021.

  • Lord, Abbett & Co reported no remaining Natus Medical Inc position as of Q1 2021 after selling out during the quarter.
  • Lord, Abbett & Co sold 87,562 Natus Medical Inc shares in Q1 2021, an estimated $1.75M.
  • Lord, Abbett & Co first reported a position in Natus Medical Inc in Q2 2019 and held it in 7 quarters.
  • Lord, Abbett & Co's Natus Medical Inc position peaked at $14.8M in Q4 2019.
  • 156 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2021.

Based on Lord, Abbett & Co's 13F filing for Q1 2021, filed 11 May 2021.